LH 徕博科

添加自选

201.320
+1.070+0.53%

收盘价 05/03 16:00 (美东)

200.831
-0.489-0.24%

盘后 17:30 (美东)

169.70亿总市值39.71市盈率TTM

关于徕博科公司

徕博科公司是一家生命科学公司，致力于提供重要信息，帮助卫生专业人员做出明确而自信的决定。它通过药物开发和诊断部门运作。药物开发部门包括先导优化、临床前安全性评估、分析服务、临床试验、中心实验室、生物标志物和伴随诊断、市场准入和技术解决方案。诊断部门包括初级保健、妇女健康、专科医学、肿瘤学、ACOs以及医院和卫生系统。

公司介绍

公司代码LH

公司名称徕博科

上市日期1991/04/24

成立日期1971

CEOMr. Adam H. Schechter

所属市场纽交所

员工数量67000

证券类型海外普通股

年结日12-31

公司地址358 South Main Street

城市Burlington

省份北卡罗来纳州

国家美国

邮编27215-5837

电话1-336-229-1127

网址http://www.labcorp.com

董事高管

姓名
职务
年薪

Adam H. Schechter
Chairman of the Board, President and Chief Executive Officer
1597.94万

Megan D. Bailey
Executive Vice President, Chief Strategy and Transformation Officer
--

Amy B. Summy
Executive Vice President and Chief Marketing Officer
--

Peter J. Wilkinson
Senior Vice President and Chief Accounting Officer
--

Glenn A. Eisenberg
Executive Vice President and Chief Financial Officer
495.68万

Lance V. Berberian
Executive Vice President and Chief Information and Technology Officer
--

Mark Schroeder
Executive Vice President, President, Diagnostics and Chief Operations Officer
379.51万

Sandra D. van der Vaart
Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
--

Brian J. Caveney, J.D.,M.D.,M.P.H.
Executive Vice President, President, Early Development Research Laboratories and Chief Medical and Scientific Officer
347.64万